INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes.
Zheng Cindy X, Moster Marlene R, Khan M Ali, Chiang Allen, Garg Sunir J, Dai Yang, Waisbourd Michael
AI Summary
This study found rare, severe endophthalmitis after glaucoma drainage implant surgery, often linked to implant erosion. Prompt diagnosis and treatment, including GDI removal, are crucial for better visual outcomes.
Abstract
Purpose
To report the clinical features, microbial spectrum, and treatment outcomes of endophthalmitis after glaucoma drainage implant (GDI) surgery.
Methods
Records of patients diagnosed with endophthalmitis after GDI surgery were reviewed. Data on clinical course, microbiological laboratory results, and treatment were analyzed.
Results
Of 1,891 eyes that underwent GDI surgery, 14 eyes (0.7%) developed endophthalmitis. The mean time interval between GDI surgery and diagnosis of endophthalmitis was 2.6 ± 3.2 years (median, 1.3 years; range, 11 days-11.4 years). For initial treatment, 13/14 eyes underwent vitreous tap and injection of intravitreal antibiotics and 1/14 eyes underwent primary pars plana vitrectomy. Three additional eyes underwent pars plana vitrectomy because of deteriorating clinical course. Glaucoma drainage implant erosion was present in 9/14 eyes. All 9 eroded GDIs were surgically removed within a mean of 9 ± 5 days (range 2-29 days) after diagnosis of endophthalmitis. Overall, mean logarithm of the minimum angle of resolution best-corrected visual acuity worsened from 0.7 ± 0.7 (Snellen equivalent 20/100) at baseline to 1.6 ± 1.1 (Snellen equivalent 20/800) at final follow-up (P = 0.005). Mean duration between the onset of symptoms and presentation was significantly longer in patients with decreased final best-corrected visual acuity (>2 Snellen lines) compared to patients with stable final best-corrected visual acuity (6.8 vs. 1.0 days; P = 0.005).
Conclusion
Glaucoma drainage implant-related endophthalmitis is rare and often associated with GDI erosion. Patients who presented earlier after the onset of symptoms had better final visual outcomes. Prompt evaluation and treatment is required, often with removal of the eroded GDI.
MeSH Terms
Shields Classification
Key Concepts5
Infectious endophthalmitis developed in 14 out of 1,891 eyes (0.7%) that underwent glaucoma drainage implant (GDI) surgery.
The mean time interval between glaucoma drainage implant (GDI) surgery and diagnosis of endophthalmitis was 2.6 ± 3.2 years (median, 1.3 years; range, 11 days-11.4 years) in 14 eyes that developed endophthalmitis after GDI surgery.
Glaucoma drainage implant (GDI) erosion was present in 9 out of 14 eyes that developed endophthalmitis after GDI surgery.
The mean logarithm of the minimum angle of resolution best-corrected visual acuity worsened from 0.7 ± 0.7 (Snellen equivalent 20/100) at baseline to 1.6 ± 1.1 (Snellen equivalent 20/800) at final follow-up (P = 0.005) in 14 eyes that developed endophthalmitis after glaucoma drainage implant surgery.
The mean duration between the onset of symptoms and presentation was significantly longer in patients with decreased final best-corrected visual acuity (>2 Snellen lines) (6.8 days) compared to patients with stable final best-corrected visual acuity (1.0 day) (P = 0.005) among patients who developed endophthalmitis after glaucoma drainage implant surgery.
Related Articles5
Lifelong experience of modified osteo-odonto-keratoprosthesis implantation over 50 years.
Cohort StudyEfficacy of Foldable Capsular Vitreous Body Implants Filled With Light or Heavy Silicone Oil in the Treatment of Silicone Oil-dependent Eyes.
Case SeriesDifferent patterns in the corneal endothelial cell loss after pars plana and pars limbal insertion of the Baerveldt glaucoma implant.
Cohort StudyChallenges in management of the Boston Keratoprosthesis Type 1.
ReviewClinical characteristics and mortality rates for suprachoroidal hemorrhage: seven-year experience at a tertiary eye center.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.